TP53 and cancer: Thus, certain p53 mutants lack the sequence‐specific transactivation ability and contribute to the acquisition and/or maintenance of malignant phenotypes of cancer tissues such as serious chemoresistance, indicating that the sequence‐specific transcriptional activity of p53 is tightly linked to its tumor‐suppressive potential 4, 5.